pharmaphorum January 14, 2019
As technology and traditional healthcare converge, some trends in cutting-edge digital health innovation are emerging.
Andrew Thompson, CEO of Proteus, made a bold claim in his opening keynote at the recent Frontiers Health conference, stating that the FDA approval of Abilify MyCite, combining his company’s digital tracking technology with Otsuka’s schizophrenia medicine, represented the biggest revolution in medicine in over 30 years.
He told the audience at Berlin’s historic Funkhaus venue in November that he believes Proteus is driving the birth of an entirely new industry, called ‘digital medicines’, in the same way...
Today's Sponsors
Today's Sponsor